Literature DB >> 6134625

Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.

M Eckert, G Cocco, C Strozzi, P Heizmann, C Sfrisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6134625     DOI： 10.1007/bf00609890

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].

Authors:  A Rostan
Journal:  Schweiz Rundsch Med Prax       Date:  1978-01-03

2.  [Pharmacokinetics of bufuralol in man].

Authors:  L Balant; R J Francis; J M Tschopp; D Tinguely; J Estreicher; J Fabre
Journal:  Pharm Acta Helv       Date:  1978

3.  Determination of bufuralol and its major metabolites in plasma by high-performance liquid chromatography.

Authors:  P Haefelfinger
Journal:  J Chromatogr       Date:  1980-12-12

4.  Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.

Authors:  D Magometschnigg; J Bonelli; G Kaik; H Rameis
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-08

5.  The genetic control of bufuralol metabolism in man.

Authors:  P Dayer; L Balant; F Courvoisier; A Kupfer; A Kubli; A Gorgia; J Fabre
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

6.  Influence of renal failure on the hepatic clearance of bufuralol in man.

Authors:  L Balant; R J Francis; T N Tozer; A Marmy; J M Tschopp; J Fabre
Journal:  J Pharmacokinet Biopharm       Date:  1980-10
  6 in total
  3 in total

1.  Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol.

Authors:  P Dayer; L Balant; A Kupfer; R Striberni; T Leemann
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.

Authors:  G D Johnston; M B Finch; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Pharmacodynamic and pharmacokinetic studies on bufuralol in man.

Authors:  T H Pringle; R J Francis; P B East; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.